tiprankstipranks

Lori Anne Kunkel Insider Profile

4 Followers
Lori Anne Kunkel, Director at Loxo Oncology, holds 22.20K shares in Curis (Ticker: CRIS), holds 0.00 shares in Loxo Oncology (Ticker: LOXO), holds ― shares in Forte Biosciences (Ticker: FBRX).
tipranks
Lori Anne Kunkel

Lori Anne Kunkel
Loxo Oncology (LOXO)
Director

Not Ranked
Lori Anne Kunkel has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$32K
100.00%
0.00%
0.00%
A breakdown of Lori Anne Kunkel's holdings

Insider Roles

Curis
(CRIS)
Director
Forte Biosciences
(FBRX)
Director
Oric Pharmaceuticals
(ORIC)
Director
Roles that Lori Anne Kunkel holds in companies

Most Profitable Insider Trade

Stock:
Loxo Oncology
(LOXO)
Rating:Informative Sell
Date:Jun 18, 2018 - Jun 18, 2019
Return:-31.00%
The most profitable trade made by Lori Anne Kunkel

Lori Anne Kunkel's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
LOXO
Loxo Oncology
Oct 03, 2018
Uninformative Sell
851.80K
$0.00
Curis
Jan 25, 2019
Director
Uninformative Sell
15.54K
$31.97K
Forte Biosciences
Director
Oric Pharmaceuticals
Director
PCYC
Pharmacyclics
May 01, 2013
Uninformative Buy
21.24K
List of latest transactions for each holding click on a transaction to see Lori Anne Kunkel's performance on stock

Lori Anne Kunkel insider profile FAQ

What is the percentage of profitable transactions made by Lori Anne Kunkel?
The percentage of profitable transactions made by Lori Anne Kunkel is ―.
    What is the average return per transaction made by Lori Anne Kunkel?
    The average return per transaction made by Lori Anne Kunkel is ―.
      What stocks does Lori Anne Kunkel hold?
      Lori Anne Kunkel holds: LOXO, CRIS, FBRX, ORIC, PCYC stocks.
        What was Lori Anne Kunkel’s latest transaction?
        Lori Anne Kunkel latest transaction was an Uninformative Sell of $15.54K.
          What was Lori Anne Kunkel's most profitable transaction?
          Lori Anne Kunkel’s most profitable transaction was an Informative Sell of LOXO stock on June 18, 2018. The return on the trade was -31.00%.
            What is Lori Anne Kunkel's role in Loxo Oncology?
            Lori Anne Kunkel's role in Loxo Oncology is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.